BACKGROUND: People with useful speech after regression constitute a distinct group of those with mutation-positive Rett disorder, 6% (20/331) reported among mutation-positive people in the British Survey. We aimed to determine the physical, mental and genetic characteristics of this group and to gain insight into their experience of Rett syndrome. METHODS: Clinical and molecular data for people with Rett, aged 10 or more years at follow-up (the study group, n = 13), with the ability to converse and a MECP2 mutation are presented. They were compared with an age-matched control group (n = 110), who could not converse and had a pathogenic MECP2 mutation. RESULTS: The study group differed significantly from the control group with regard to their disease severity (P < 0.001); feeding difficulty scores (P < 0.001); health scores (P < 0.001); epilepsy (P < 0.001); head circumference (P < 0.004); age at onset of the regression period (P < 0.001) (six in the study group did not regress) and mutation frequency (C-terminal deletions P = 0.014, R133C P < 0.006). The results indicate that favourable skewing of X-inactivation is only present in a small proportion of mild cases. Speech was fragmented with a soft, breathless quality, and all but two had obviously irregular breathing. One person with an R168X mutation preferred signing to speech. All enjoyed interpersonal contact, showing affection and preferring people to objects, clearly distinguishing the condition from autism. Most were habitually anxious. Music was a source of pleasure and relaxation also providing a valuable educational asset. Even in these most able cases, understanding was severely restricted in most and little initiative was shown. CONCLUSIONS: While the Rett profile is present in these people they are commonly not classic, and the presence of speech, good head growth and lack of regression may lead to missed diagnoses. A strong association was demonstrated between this milder form of the disease and R133C and C-terminal deletions.
BACKGROUND:People with useful speech after regression constitute a distinct group of those with mutation-positive Rett disorder, 6% (20/331) reported among mutation-positive people in the British Survey. We aimed to determine the physical, mental and genetic characteristics of this group and to gain insight into their experience of Rett syndrome. METHODS: Clinical and molecular data for people with Rett, aged 10 or more years at follow-up (the study group, n = 13), with the ability to converse and a MECP2 mutation are presented. They were compared with an age-matched control group (n = 110), who could not converse and had a pathogenic MECP2 mutation. RESULTS: The study group differed significantly from the control group with regard to their disease severity (P < 0.001); feeding difficulty scores (P < 0.001); health scores (P < 0.001); epilepsy (P < 0.001); head circumference (P < 0.004); age at onset of the regression period (P < 0.001) (six in the study group did not regress) and mutation frequency (C-terminal deletions P = 0.014, R133C P < 0.006). The results indicate that favourable skewing of X-inactivation is only present in a small proportion of mild cases. Speech was fragmented with a soft, breathless quality, and all but two had obviously irregular breathing. One person with an R168X mutation preferred signing to speech. All enjoyed interpersonal contact, showing affection and preferring people to objects, clearly distinguishing the condition from autism. Most were habitually anxious. Music was a source of pleasure and relaxation also providing a valuable educational asset. Even in these most able cases, understanding was severely restricted in most and little initiative was shown. CONCLUSIONS: While the Rett profile is present in these people they are commonly not classic, and the presence of speech, good head growth and lack of regression may lead to missed diagnoses. A strong association was demonstrated between this milder form of the disease and R133C and C-terminal deletions.
Authors: Hayley Archer; Julie Evans; Helen Leonard; Lyn Colvin; David Ravine; John Christodoulou; Sarah Williamson; Tony Charman; Mark E S Bailey; Julian Sampson; Nicholas de Klerk; Angus Clarke Journal: J Med Genet Date: 2006-08-11 Impact factor: 6.318
Authors: Tatiana Nikitina; Xi Shi; Rajarshi P Ghosh; Rachel A Horowitz-Scherer; Jeffrey C Hansen; Christopher L Woodcock Journal: Mol Cell Biol Date: 2006-11-13 Impact factor: 4.272
Authors: Peter B Marschik; Ralf Vollmann; Katrin D Bartl-Pokorny; Vanessa A Green; Larah van der Meer; Thomas Wolin; Christa Einspieler Journal: Dev Neurorehabil Date: 2013-07-19 Impact factor: 2.308
Authors: Katrin D Bartl-Pokorny; Peter B Marschik; Jeff Sigafoos; Helen Tager-Flusberg; Walter E Kaufmann; Tobias Grossmann; Christa Einspieler Journal: Res Dev Disabil Date: 2013-07-24
Authors: Deidra Young; Lakshmi Nagarajan; Nick de Klerk; Peter Jacoby; Carolyn Ellaway; Helen Leonard Journal: Brain Dev Date: 2007-05-24 Impact factor: 1.961
Authors: Deidra J Young; Ami Bebbington; Alison Anderson; David Ravine; Carolyn Ellaway; Alpana Kulkarni; Nick de Klerk; Walter E Kaufmann; Helen Leonard Journal: Eur J Pediatr Date: 2007-08-08 Impact factor: 3.183
Authors: Peter B Marschik; Walter E Kaufmann; Christa Einspieler; Katrin D Bartl-Pokorny; Thomas Wolin; Giorgio Pini; Dejan B Budimirovic; Michele Zappella; Jeff Sigafoos Journal: Res Dev Disabil Date: 2012-06-13
Authors: Gillian S Townend; Katrin D Bartl-Pokorny; Jeff Sigafoos; Leopold M G Curfs; Sven Bölte; Luise Poustka; Christa Einspieler; Peter B Marschik Journal: Res Dev Disabil Date: 2015-07-07
Authors: Peter B Marschik; Walter E Kaufmann; Jeff Sigafoos; Thomas Wolin; Dajie Zhang; Katrin D Bartl-Pokorny; Giorgio Pini; Michele Zappella; Helen Tager-Flusberg; Christa Einspieler; Michael V Johnston Journal: Res Dev Disabil Date: 2013-02-09